Clinical effect of different surgical approaches for deep orbital cavernous hemangioma
外科手术不同手术入路治疗眼眶深部海绵状血管瘤的临床效果

摘要

目的 对眼眶深部海绵状血管瘤（cavernous hemangioma，CH）患者采取不同外科手术入路方式后的临床治疗效果。方法 本次研究的主要对象为：眼眶深部CH患者（共40例，病例选取时间开始于2020年3月，截止时间为2021年3月）。按照数字随机表法分为4组，一组为E组（实施经结膜入路前路开眶术），共纳入10例眼眶深部CH患者；一组为F组（实施经皮肤入路前路开眶术），共纳入10例眼眶深部CH患者；一组为M组（实施外侧开眶术），共纳入10例眼眶深部CH患者；一组为N组（实施内侧联合外侧入路开眶术），共纳入10例眼眶深部CH患者。结果 对比4组术后并发症发生率、术后残留率、术后12个月复发率、术后视力，结果表明4组比较无差异（P＞0.05）。对比4组手术前炎症因子表达水平，结果表明4组比较无差异（P＞0.05）；对比4组手术后炎症因子表达水平，结果表明4组比较无差异（P＞0.05）。结论 对眼眶深部CH患者实施经结膜入路前路开眶术、实施经皮肤入路前路开眶术、实施外侧开眶术以及实施内侧联合外侧入路开眶术等所取得的临床效果相近。

Abstract

Objective The clinical treatment effect of the patients with deep orbital cavernous hemangioma (cavernous hemangioma, CH).
Methods The main subjects of this study were: patients with deep orbital CH (a total of 40 cases were started in March 2020 and ended in March 2021). There were four groups, one in group E (anterior orbital approach with transconjunctival approach), 10 deep orbital CH patients, group F (anterior transorbital approach), group M (10 deep orbital CH patients), and group N (medial combined lateral orbital approach), and 10 patients with deep orbital CH).
Results Comparing the postoperative complication rate, postoperative residual rate, 12 months postoperative recurrence rate, and postoperative visual acuity in the four groups, there was no difference between the four groups (P> 0.05). Comparing the expression levels of inflammatory factors before surgery, the results showed no difference (P> 0.05) in the four groups (P> 0.05).
Conclusion   Transval orbital approach, transcutaneous approach, lateral orbital approach and medial and lateral approach.